idebenone: Clinical Trials

11 trials of idebenone, newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

6 completed, 2 terminated, 2 withdrawn, 1 recruiting. 11 Phase 3, 1 Phase 2.

By phase and status

PhaseTrialsStatus
Phase 311Completed 6, Terminated 2, Withdrawn 2, Recruiting 1
Phase 21Withdrawn 1

Follow idebenone: new trials by email Literature Review of idebenone trials Research Report on idebenone

Trials (filtered) newest first · largest first

All 11 trials

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
Idebenone for the Preventive Treatment of Migraine
Placebo, 90mg Idebenone, 270mg Idebenone - Migraine Disorders, Headache Disorders
Phase 3RecruitingSecond Affiliated Hospital, Zhejiang University, School of Medicine1802021-12-082025-05-15
A Study of Efficacy and Safety of Idebenone Vs. Placebo in Prodromal Parkinson Disease
Idebenone, Placebo oral tablet - REM Sleep Behavior Disorder, Parkinson Disease
Phase 2 / Phase 3WithdrawnSecond Affiliated Hospital, Zhejiang University, School of Medicine2020-01-012025-01-07
Phase III Study With Idebenone in Patients With Duchenne Muscular Dystrophy (SIDEROS-E)
idebenone 150 mg film-coated tablets - Duchenne Muscular Dystrophy
Phase 3TerminatedSanthera Pharmaceuticals1612018-07-042021-12-03
A Phase III Double-blind Study With Idebenone in Patients With Duchenne Muscular Dystrophy (DMD) Taking Glucocorticoid Steroids
Idebenone 150 mg film-coated tablets, placebo - Duchenne Muscular Dystrophy (DMD)
Phase 3TerminatedSanthera Pharmaceuticals2552016-09-012021-12-03
Patient Reported Outcomes in Friedreich's Ataxia Patients After Withdrawal From Treatment With Idebenone (PROTI)
Idebenone, Placebo - Friedreich's Ataxia
Phase 3CompletedSanthera Pharmaceuticals292011-04-012016-03-09
Phase III Study of Idebenone in Duchenne Muscular Dystrophy (DMD)
Placebo, Idebenone - Muscular Dystrophy, Duchenne, Ambulatory Care
Phase 3CompletedSanthera Pharmaceuticals652009-07-012015-10-19
Study to Assess the Safety and Tolerability of Idebenone in the Treatment of Friedreich's Ataxia Patients
Idebenone - Friedreich's Ataxia
Phase 3CompletedSanthera Pharmaceuticals682008-07-012023-07-11
Study to Assess the Efficacy, Safety and Tolerability of Idebenone in the Treatment of Friedreich's Ataxia
Idebenone, Placebo - Friedreich's Ataxia
Phase 3CompletedSanthera Pharmaceuticals702007-12-012023-07-11
Long-Term Safety and Tolerability of Idebenone in Friedreich's Ataxia Patients (MICONOS Extension)
idebenone - Freidreich's Ataxia
Phase 3CompletedSanthera Pharmaceuticals2002007-06-012018-03-05
A Study of Efficacy, Safety and Tolerability of Idebenone in the Treatment of Friedreich's Ataxia (FRDA) Patients
idebenone, Placebo - Friedreich's Ataxia
Phase 3CompletedSanthera Pharmaceuticals2322006-04-012016-06-27
Study With Idebenone in Patients With Chronic Vision Loss Due to Leber's Hereditary Optic Neuropathy (LHON)
Idebenone, Placebo - Leber's Hereditary Optic Neuropathy
Phase 3WithdrawnSanthera Pharmaceuticals2014-08-22

Conditions studied

Friedreich Ataxia (4)  ·  Muscular Dystrophy, Duchenne (3)  ·  Headache Disorders (1)  ·  Migraine Disorders (1)  ·  Mitochondrial Diseases (1)  ·  Optic Atrophy, Hereditary, Leber (1)  ·  Parkinson Disease (1)  ·  REM Sleep Behavior Disorder (1)  ·  Respiratory Aspiration (1)

Sponsors

Santhera Pharmaceuticals (9)  ·  Second Affiliated Hospital, Zhejiang University, School of Medicine (2)

Countries

Austria (6)  ·  Germany (6)  ·  Belgium (5)  ·  France (5)  ·  Netherlands (5)  ·  United States (5)  ·  United Kingdom (4)  ·  Italy (3)  ·  Spain (3)  ·  Switzerland (3)  ·  China (2)  ·  Sweden (2)  ·  Bulgaria (1)  ·  Hungary (1)  ·  Ireland (1)

Top investigators

David Lynch, MD (2)  ·  Nick Wood, Professor (2)  ·  Susan Perlman, MD (2)  ·  Ana Camacho Salas, MD (1)  ·  Ass. Prof. Jan Verschuuren, MD, PhD (1)  ·  Baorong Zhang, MD (1)  ·  Barry Byrne, MD (1)  ·  Bryan W. Burnette, MD (1)  ·  Craig McDonald, MD (1)  ·  Dr. Pierre-Yves Jeannet, Médecin Associé, MER (1)  ·  Dr. Ulrike Schara, MD, PhD (1)  ·  Ericka Simpson, MD (1)  ·  Gihan Tennekoon, MD (1)  ·  Janbernd Kirschner, MD (1)

Results publications

PMID 21779958, PMID 11972582, PMID 20065258, PMID 20697044, PMID 21392622, PMID 21586650, PMID 21788663, PMID 25907158, PMID 25916335, PMID 28132202, PMID 28189481, PMID 29298622